Circumcision and HIV: Difference between revisions
WikiModEn2 (talk | contribs) Insert new South Africa sub-section; Wikify Langerhans cells. |
m wikify McAllister; adjust date entries |
||
| Line 27: | Line 27: | ||
| publisher= | | publisher= | ||
| work= | | work= | ||
| date= | | date=2008-02 | ||
| accessdate=2011-06-01 | | accessdate=2011-06-01 | ||
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| Line 37: | Line 37: | ||
| publisher= | | publisher= | ||
| work= | | work= | ||
| date= | | date=2007-03 | ||
| accessdate=2011-06-01 | | accessdate=2011-06-01 | ||
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| Line 47: | Line 47: | ||
| publisher= | | publisher= | ||
| work= | | work= | ||
| date= | | date=2011-01-09 | ||
| accessdate=2011-06-01 | | accessdate=2011-06-01 | ||
}}</ref> | }}</ref> | ||
| Line 66: | Line 66: | ||
|pubmedCID= | |pubmedCID= | ||
|DOI=10.1371/journal.pmed.0020298#r1326 | |DOI=10.1371/journal.pmed.0020298#r1326 | ||
|date= | |date=2006-10 | ||
|accessdate= | |accessdate= | ||
}}</ref> In 1986, California urologist [[Aaron J. Fink| Aaron J. Fink]], (1926-1994) adopted this idea,<ref>{{REFbook | }}</ref> In 1986, California urologist [[Aaron J. Fink| Aaron J. Fink]], (1926-1994) adopted this idea,<ref>{{REFbook | ||
| Line 103: | Line 103: | ||
|pubmedCID= | |pubmedCID= | ||
|DOI=10.1097/00002030-200010200-00018 | |DOI=10.1097/00002030-200010200-00018 | ||
|date= | |date=2000-10 | ||
|accessdate= | |accessdate= | ||
}}</ref> without any kind of proof whatsoever. | }}</ref> without any kind of proof whatsoever. | ||
| Line 497: | Line 497: | ||
|publisher=USAID | |publisher=USAID | ||
|format=PDF | |format=PDF | ||
|date= | |date=2002-01 | ||
|accessdate=2019-09-29 | |accessdate=2019-09-29 | ||
}}</ref> By designing a trial to "detect" a minimum 50 percent reduction risk in HIV, these researchers might have artificially created the clinical setting to observe the effect they were looking to discover. | }}</ref> By designing a trial to "detect" a minimum 50 percent reduction risk in HIV, these researchers might have artificially created the clinical setting to observe the effect they were looking to discover. | ||
| Line 510: | Line 510: | ||
|title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns | |title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns | ||
|journal=J Law Med | |journal=J Law Med | ||
|date= | |date=2011-12 | ||
|volume=19 | |volume=19 | ||
|issue=2 | |issue=2 | ||
| Line 561: | Line 561: | ||
== Real-world == | == Real-world == | ||
An analysis of HIV prevalence compared to circumcision status in sub-Saharan Africa concluded that male circumcision is not associated with reduced HIV prevalence.<ref>Garenne M. Long-term population effects of male circumcision in generalized HIV epidemics in sub-Saharan Africa. Afr J AIDS Res 2008;7(1):1– 8.</ref> Another study on circumcision prevalence compared to HIV in the general South African population concluded: “Circumcision had no protective effect on HIV transmission.”<ref>Connolly C, Simbayi LC, Shanmugam R, Nqeketo A. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002. S Afr Med J 2008;98:789 –94.</ref> When commercial sex worker patterns are controlled, male circumcision is not signifıcantly associated with lower HIV prevalence.<ref>Talbott JR. Size matters: the number of prostitutes and the global HIV/AIDS pandemic. PloS One 2007;2(6):e543. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000543</ref> Mathematical impact modeling of circumcision, antiretroviral therapy (ART), and condom use for South Africa concluded: “Male circumcision was found to have considerably lower impact than condom use or anti-retroviral therapy on HIV infection rates and death rates.”<ref>Lima V, Anema A, Wood R, et al. The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model. 5th IAS Conference on HIV Treatment, Pathogenesis and Prevention, Cape Town, abstract WECA105, 2009.</ref> Both the U.S. and sub-Saharan Africa have relatively high incidence rates of HIV infection, considering that about 75% of U.S. men and about 70% of sub-Saharan African men are circumcised—higher percentages than in most other regions or countries with lower prevalence of HIV.<ref>Green | An analysis of HIV prevalence compared to circumcision status in sub-Saharan Africa concluded that male circumcision is not associated with reduced HIV prevalence.<ref>Garenne M. Long-term population effects of male circumcision in generalized HIV epidemics in sub-Saharan Africa. Afr J AIDS Res 2008;7(1):1– 8.</ref> Another study on circumcision prevalence compared to HIV in the general South African population concluded: “Circumcision had no protective effect on HIV transmission.”<ref>Connolly C, Simbayi LC, Shanmugam R, Nqeketo A. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002. S Afr Med J 2008;98:789 –94.</ref> When commercial sex worker patterns are controlled, male circumcision is not signifıcantly associated with lower HIV prevalence.<ref>Talbott JR. Size matters: the number of prostitutes and the global HIV/AIDS pandemic. PloS One 2007;2(6):e543. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000543</ref> Mathematical impact modeling of circumcision, antiretroviral therapy (ART), and condom use for South Africa concluded: “Male circumcision was found to have considerably lower impact than condom use or anti-retroviral therapy on HIV infection rates and death rates.”<ref>Lima V, Anema A, Wood R, et al. The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model. 5th IAS Conference on HIV Treatment, Pathogenesis and Prevention, Cape Town, abstract WECA105, 2009.</ref> Both the U.S. and sub-Saharan Africa have relatively high incidence rates of HIV infection, considering that about 75% of U.S. men and about 70% of sub-Saharan African men are circumcised—higher percentages than in most other regions or countries with lower prevalence of HIV.<ref>{{REFjournal | ||
|last=Green | |||
|first=L.W. | |||
|last2=Travis | |||
|first2=J.W. | |||
|last3=McAllister | |||
|first3=R.G. | |||
|author3-link=Ryan McAllister | |||
|last4=Peterson | |||
|first4=K.W. | |||
|last5=Vardanyan | |||
|first5=A.N. | |||
|last6=Craig | |||
|first6=A. | |||
|title=Male circumcision and HIV prevention insufficient evidence and neglected external validity | |||
|journal=Am J Prev Med | |||
|date=2010-11 | |||
|volume=39 | |||
|issue=5 | |||
|pages=479-482 | |||
|location=Department of Epidemiology and Biostatistics, University of California at San Francisco, USA | |||
|pubmedID=20965388 | |||
}}</ref> | |||
There is no clear pattern of association between male circumcision and HIV prevalence. In 10 out of 18 countries, HIV prevalence is higher amongst circumcised men.<ref>{{REFdocument | There is no clear pattern of association between male circumcision and HIV prevalence. In 10 out of 18 countries, HIV prevalence is higher amongst circumcised men.<ref>{{REFdocument | ||
| Line 591: | Line 613: | ||
|pubmedCID= | |pubmedCID= | ||
|DOI= | |DOI= | ||
| | |note=Annals of Epidemiology | ||
|accessdate=2011-06-02 | |accessdate=2011-06-02 | ||
}}</ref> | }}</ref> | ||